Thus, it becomes released in response to the action of platelet-activating factor (PAF), which induces the generation of prostaglandins (both by upregulating AA and activating COX enzymes [54]), thereby promoting vascular permeability and macular edema [55]. The gene discussed is PCLAF; the disease is macular retinal edema.